| Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study M Dreyling, W Jurczak, M Jerkeman, RS Silva, C Rusconi, M Trneny, ... The Lancet 387 (10020), 770-778, 2016 | 544 | 2016 |
| International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders J Hillengass, S Usmani, SV Rajkumar, BGM Durie, MV Mateos, S Lonial, ... The lancet oncology 20 (6), e302-e312, 2019 | 450 | 2019 |
| Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label … PG Richardson, A Oriol, M Beksac, AM Liberati, M Galli, F Schjesvold, ... The Lancet Oncology 20 (6), 781-794, 2019 | 379 | 2019 |
| Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group P Moreau, SK Kumar, J San Miguel, F Davies, E Zamagni, N Bahlis, ... The Lancet Oncology 22 (3), e105-e118, 2021 | 236 | 2021 |
| The production processes and biological effects of intravenous immunoglobulin AF Barahona Afonso, CMP João Biomolecules 6 (1), 15, 2016 | 116 | 2016 |
| B cell-dependent TCR diversification C João, BM Ogle, C Gay-Rabinstein, JL Platt, M Cascalho The Journal of Immunology 172 (8), 4709-4716, 2004 | 104 | 2004 |
| Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study S Rule, W Jurczak, M Jerkeman, C Rusconi, M Trneny, F Offner, ... Leukemia 32 (8), 1799-1803, 2018 | 103 | 2018 |
| Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma C Joao, LF Porrata, DJ Inwards, SM Ansell, IN Micallef, PB Johnston, ... Bone Marrow Transplantation 37 (9), 865-871, 2006 | 89 | 2006 |
| The immune microenvironment in multiple myeloma: Friend or foe? R Lopes, J Caetano, B Ferreira, F Barahona, EA Carneiro, C Joao Cancers 13 (4), 625, 2021 | 45 | 2021 |
| Direct measurement of lymphocyte receptor diversity BM Ogle, M Cascalho, C Joao, W Taylor, LJ West, JL Platt Nucleic acids research 31 (22), e139-e139, 2003 | 39 | 2003 |
| Passive serum therapy to immunomodulation by IVIG: a fascinating journey of antibodies C João, VS Negi, MD Kazatchkine, J Bayry, SV Kaveri The Journal of Immunology 200 (6), 1957-1963, 2018 | 34 | 2018 |
| The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018 G Palladini, S Schönland, G Merlini, P Milani, A Jaccard, F Bridoux, ... Blood cancer journal 13 (1), 19, 2023 | 33 | 2023 |
| Liquid biopsies for multiple myeloma in a time of precision medicine B Ferreira, J Caetano, F Barahona, R Lopes, E Carneiro, B Costa-Silva, ... Journal of Molecular Medicine 98, 513-525, 2020 | 31 | 2020 |
| Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low‐dose dexamethasone: A pooled analysis P Moreau, MA Dimopoulos, PG Richardson, DS Siegel, M Cavo, ... European Journal of Haematology 99 (3), 199-206, 2017 | 29 | 2017 |
| Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells N Costa, AE Pires, AM Gabriel, LF Goulart, C Pereira, B Leal, AC Queiros, ... Journal of clinical immunology 33, 349-360, 2013 | 28 | 2013 |
| Cytogenetic abnormalities in MALT lymphomas and their precursor lesions from different organs. A fluorescence in situ hybridization (FISH) study C Joao, P Farinha, MG Da Silva, C Martins, M Crespo, J Cabecadas Histopathology 50 (2), 217-224, 2007 | 27 | 2007 |
| Immunoglobulin promotes the diversity and the function of T cells C João, BM Ogle, S Geyer European journal of immunology 36 (7), 1718-1728, 2006 | 27 | 2006 |
| Long‐term survival in multiple myeloma C Joao, C Costa, I Coelho, MJ Vergueiro, M Ferreira, MG da Silva Clinical case reports 2 (5), 173-179, 2014 | 26 | 2014 |
| Immunoglobulin is a highly diverse self-molecule that improves cellular diversity and function during immune reconstitution C João Medical hypotheses 68 (1), 158-161, 2007 | 26 | 2007 |
| Multiple myeloma in Portugal: burden of disease and cost of illness M Neves, F Trigo, B Rui, C João, P Lúcio, N Mariana, J Mendes, ... Pharmacoeconomics 39, 579-587, 2021 | 19 | 2021 |
Ana Filipa Barahona AfonsoLab technician, Fundação ChampalimaudEmail yang diverifikasi di research.fchampalimaud.org